How has ANI Pharmaceuticals's net gains (losses) on investments changed year-over-year?

ANI Pharmaceuticals's net gains (losses) on investments increased by 724.6% year-over-year, from -$921K to $5.75M.

What does net gains (losses) on investments mean?

Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.

ANI Pharmaceuticals ANIP Net gains (losses) on investments

Net gains (losses) on investments at other companies

AnaptysBio, Inc.ANAB

$8K-99.5%

ALN

Alnylam PharmaceuticalsALNY

$0+100%

AmgenAMGN

-$143M-111%

Catalyst PharmaceuticalCPRX

$4.75M+79.7%

IncyteINCY

$6.59M+591%

United TherapeuticsUTHR

——

Segments

By segment

See full

Generics and Other$0—

Rare Disease and Brands$0—

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.88B+18.3%

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's net gains (losses) on investments?: ANI Pharmaceuticals (ANIP) reported net gains (losses) on investments of $5.75M in Q1 2026.
How has ANI Pharmaceuticals's net gains (losses) on investments changed year-over-year?: ANI Pharmaceuticals's net gains (losses) on investments increased by 724.6% year-over-year, from -$921K to $5.75M.
What does net gains (losses) on investments mean?: Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.